Join the Coronary Artery Disease (CAD) group to help and get support from people like you.
Coronary Artery Disease (CAD) News (Page 2)
Related terms: Arteriosclerotic Heart Disease, Coronary Heart Disease (CHD), Coronary Heart Disease, CAD, CHD
COVID-19 Hospitalization Equivalent to Coronary Artery Disease for MACE Risk
WEDNESDAY, Oct. 9, 2024 – Hospitalization for COVID-19 represents a coronary artery disease risk equivalent, contributing to an increased risk for major adverse cardiovascular events (MACE),...
Lower Potassium Threshold After CABG Safe for A-Fib Prevention
WEDNESDAY, Sept. 4, 2024 – Potassium supplementation at a threshold of
Women Undergoing CABG More Likely to Get Care at Low-Quality Hospitals
MONDAY, July 29, 2024 – Female Medicare beneficiaries undergoing coronary artery bypass grafting are more likely to receive care at low-quality hospitals than male beneficiaries, with a greater sex...
Noncontact Facial Infrared Thermography Model Can Predict Coronary Artery Disease
WEDNESDAY, June 5, 2024 – A noncontact facial infrared thermography (IRT) machine learning model can predict coronary artery disease (CAD), according to a study published online June 3 in BMJ Health...
Volume of Leisure-Time Physical Activity Not Tied to Coronary Artery Calcium
WEDNESDAY, May 22, 2024 – Ongoing leisure-time physical activity, even at high volumes, is not associated with coronary artery calcium (CAC) progression, a marker of atherosclerotic cardiovascular...
You May Not Have to Fast Before Catheter-Based Heart Test, Study Suggests
FRIDAY, May 3, 2024 – Folks undergoing cardiac catheterization procedures to diagnose heart problems may be able to safely skip the traditional pre-op fasting that's now the norm, new research...
Social Determinants of Health Tied to Atherosclerotic CVD Risk
WEDNESDAY, May 1, 2024 – Both individual- and area-level social determinants of health (SDOH) are associated with atherosclerotic cardiovascular disease (ASCVD) risk, according to a study published...
FDA Approves Norliqva (amlodipine) Oral Solution for Hypertension and Coronary Artery Disease
February 28, 2022 - The U.S. Food and Drug Administration has approved Norliqva (amlodipine) oral solution for the treatment of: Hypertension in adults and children 6 years and older, to lower blood...
Brilinta Approved in the US to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients with Coronary Artery Disease
June 1, 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with coronary artery disease (CAD), the most ...
FDA Approves Gadavist (gadobutrol) Contrast Agent for Use in Cardiac MR in Adult Patients with Known or Suspected Coronary Artery Disease
WHIPPANY, N.J., July 15, 2019 /PRNewswire/ – Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use in cardiac magnetic resonance (MR)...
FDA Approves Katerzia (amlodipine) Oral Suspension for Pediatric Patients 6 Years of Age and Older
WOBURN, Mass. (July 10, 2019) – Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, ann...
FDA Approves Xarelto to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)
TITUSVILLE, NJ, October 11, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) to r...
Further information
Related drug support groups
lisinopril, amlodipine, Xarelto, Brilinta, Norvasc, garlic, rivaroxaban, ticagrelor